The prevalence of lynch syndrome (DNA mismatch repair protein deficiency) in patients with primary localized prostate cancer using immunohistochemistry screening

CONCLUSIONS: In this study, immunohistochemical screening of MMR proteins for Lynch syndrome was performed in a series of prostate cancer cases. The prevalence of Lynch syndrome in localized prostate cancer was 0.8%, which is low compared with other Lynch syndrome-associated cancers.PMID:37828628 | DOI:10.1186/s13053-023-00265-1

Source: Clinical Prostate Cancer - October 12, 2023 Category: Cancer & Oncology Authors: Suguru Oka Shinji Urakami Kiichi Hagiwara Michikata Hayashida Kazushige Sakaguchi Yuji Miura Naoko Inoshita Masami Arai Source Type: research